Skip to main content
. 2023 Aug 7;10(5):e200161. doi: 10.1212/NXI.0000000000200161

Figure. Survival Analysis With Time to First Relapse in the NTZ and RTX/OCR Groups During the Period Including Pregnancy and the Year After Delivery.

Figure

NTZ = natalizumab; RTX/OCR = rituximab/ocrelizumab.